CN101683499A - Cancer curing capsule - Google Patents

Cancer curing capsule Download PDF

Info

Publication number
CN101683499A
CN101683499A CN200810121081A CN200810121081A CN101683499A CN 101683499 A CN101683499 A CN 101683499A CN 200810121081 A CN200810121081 A CN 200810121081A CN 200810121081 A CN200810121081 A CN 200810121081A CN 101683499 A CN101683499 A CN 101683499A
Authority
CN
China
Prior art keywords
radix
root
herba
cancer
fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810121081A
Other languages
Chinese (zh)
Inventor
王孙勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810121081A priority Critical patent/CN101683499A/en
Publication of CN101683499A publication Critical patent/CN101683499A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a traditional Chinese medicine formula of treating cancer, the composition are as follows: 3g Chinese caterpillar fungus, 20g lotus plumule, 20g dandelion, 13g heydyotis, 13g clematis root, 13g curcuma tuber, 13g weeping forsythia capsule, 10g buffalo horn, 6g leech, 6g phellodendron, 30g rehmanniae radix, 15g turtle shell, 3g rhizoma paridis, 9g anemarrhena, 15g blood root, 9g red sage root, 3g borneol, 9g bearded scutellaria, 20g yujing, 6g bushy sophora, 10g dodder seed, 30g astragalus root, 20g common self-heal fruit-spike, 30g patrinia, 10g lobelia chinensis, 20g gynostemma pentaphylla, 10g lycium fruit, 20g honeysuckle, 20g Chinese yam, 10g white peony root, 10g sophora flavescens, 20g radix isatidis, 10g woad root, 20g cape jasmine fruit, 15g Yedo violet, 15gtree peony bark, 6g liquorice root, the medicine is suitable for treatment of cancer in early stage and mid-term, and has advantages of low cost, nontoxic and no side-effect.

Description

Cancer curing capsule
Technical field
The present invention relates to treat the medicine of cancer, particularly a kind of medicine for the treatment of the brain cancer in early stage, mid-term, esophageal carcinoma, breast carcinoma, gastric cancer, intestinal cancer, hepatocarcinoma, pulmonary carcinoma, renal carcinoma, uterus carcinoma, ovarian cancer, osteocarcinoma and canceroderm.
Background technology
The medicine of present known treatment cancer is a lot, but curative effect is not very desirable, and the cost of manufacture height, and general patient all is difficult to bear, and the part medicine has side effect again.
Summary of the invention
In order to overcome existing curing cancer drug cost height, curative effect is remarkable inadequately, and the deficiency that side effect is arranged, the invention provides a kind of cancer curing capsule, this cancer curing capsule not only can suppress in early days, cancerous cell diffusion in mid-term and transfer, and can promote the canceration symptom to turn out cloudy and the interior equilibrium between yin and yang of human body, and can reach the positive effect that shrank 1-2 centimetre of cancerous protuberance in every month, and all adopt pure Chinese medicine, nontoxic, have no side effect, cost of manufacture is lower.
Medicinal merit reason of the present invention is: on the one hand with the Chinese medicine of the cancer that disappears kill, the diffusion of anticancer, tumor is not controlled to be enlarged, atrophy gradually strengthens immunity of human body itself on the one hand, regulates equilibrium between yin and yang, strengthening the body resistance, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, Repercusion analgesia, eliminate fully until focus, its pharmaceutical formulation is as follows:
Cordyceps 3g, Plumula Nelumbinis 20g, Herba Taraxaci 20g, Herba Hedyotidis Diffusae 13g, Radix Clematidis 13g, Radix Curcumae 13g, Fructus Forsythiae 13g, Cornu Bubali 10g, Hirudo 6g, Cortex Phellodendri 6g, Radix Rehmanniae 30g, Carapax Trionycis 15g, Rhizoma Paridis 3g, Rhizoma Anemarrhenae 9g, Radix Salviae Miltiorrhizae 15g, Radix Salviae Miltiorrhizae 9g, Borneolum Syntheticum 3g, Herba Scutellariae Barbatae 9g, beautiful smart 20g, Radix Sophorae Tonkinensis 6g, Semen Cuscutae 10g, Radix Astragali 30g, Spica Prunellae 20g, Herba Patriniae 30g, Herba Lobeliae Chinensis 10g, Herb Gynostemmae Pentaphylli 20g, Fructus Lycii 10g, Flos Lonicerae 20g, Rhizoma Dioscoreae 20g, Radix Paeoniae Alba 10g, Radix Sophorae Flavescentis 10g, Radix Isatidis 20g, Folium Isatidis 10g, Fructus Gardeniae 20g, Herba Violae 15g, Cortex Moutan 15g, Radix Glycyrrhizae 6g.
The invention has the beneficial effects as follows that cost of manufacture is low, pure Chinese medicine is made, and is nontoxic, have no side effect, and is particularly useful for the brain cancer, esophageal carcinoma, gastric cancer in early stage, mid-term etc.
The specific embodiment
By the said medicine formulation by weight, earlier it is decocted into decoction, remove medicinal residues, after being concentrated, decoction is dried into solid, and grind into fine powder incapsulates it by the capsule processing technology then again, and the content of dispersion of every capsules is controlled to 0.5 gram and gets final product.
Instructions of taking: be grown up each 5, each 2 of child, one day 3 times, the brain cancer, esophageal carcinoma, breast carcinoma, hepatocarcinoma, pulmonary carcinoma, canceroderm, osteocarcinoma, gastric cancer one after each meal, but uterus carcinoma, ovarian cancer, intestinal cancer taking medicine before meal are used.
Points for attention: cancerous cell diffusion, pathological changes can not be taken the careful clothes of anemia of pregnant woman to late period.

Claims (1)

  1. A kind of cancer curing capsule is characterized in that: according to Cordyceps 3g, Plumula Nelumbinis 20g, Herba Taraxaci 20g, Herba Hedyotidis Diffusae 13g, Radix Clematidis 13g, Radix Curcumae 13g, Fructus Forsythiae 13g, Cornu Bubali 10g, Hirudo 6g, Cortex Phellodendri 6g, Radix Rehmanniae 30g, Carapax Trionycis 15g, Rhizoma Paridis 3g, Rhizoma Anemarrhenae 9g, Radix Salviae Miltiorrhizae 15g, Radix Salviae Miltiorrhizae 9g, Borneolum Syntheticum 3g, Herba Scutellariae Barbatae 9g, beautiful smart 20g, Radix Sophorae Tonkinensis 6g, Semen Cuscutae 10g, Radix Astragali 30g, Spica Prunellae 20g, Herba Patriniae 30g, Herba Lobeliae Chinensis 10g, Herb Gynostemmae Pentaphylli 20g, Fructus Lycii 10g, Flos Lonicerae 20g, Rhizoma Dioscoreae 20g, Radix Paeoniae Alba 10g, Radix Sophorae Flavescentis 10g, Radix Isatidis 20g, Folium Isatidis 10g, Fructus Gardeniae 20g, Herba Violae 15g, Cortex Moutan 15g, the weight ratio of Radix Glycyrrhizae 6g is synthetic.
CN200810121081A 2008-09-24 2008-09-24 Cancer curing capsule Pending CN101683499A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810121081A CN101683499A (en) 2008-09-24 2008-09-24 Cancer curing capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810121081A CN101683499A (en) 2008-09-24 2008-09-24 Cancer curing capsule

Publications (1)

Publication Number Publication Date
CN101683499A true CN101683499A (en) 2010-03-31

Family

ID=42047028

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810121081A Pending CN101683499A (en) 2008-09-24 2008-09-24 Cancer curing capsule

Country Status (1)

Country Link
CN (1) CN101683499A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948885A (en) * 2014-04-01 2014-07-30 孙志芳 Traditional Chinese medicine for treating gastric cancer, and preparation method thereof
CN104398904A (en) * 2014-12-13 2015-03-11 刘江梅 Chinese herbal preparation for oral care after esophagus cancer surgery and preparation method
US20160030491A1 (en) * 2013-12-31 2016-02-04 Zhonglin Wang Pharmaceutical composition for treating aids and preparation method thereof
CN106177368A (en) * 2016-10-10 2016-12-07 南宁多灵生物科技有限公司 A kind of Chinese medicine composition treating bladder cancer
CN108853236A (en) * 2018-02-28 2018-11-23 西安交通大学 A kind of Chinese medicine compound prescription application in preparation of anti-tumor drugs

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160030491A1 (en) * 2013-12-31 2016-02-04 Zhonglin Wang Pharmaceutical composition for treating aids and preparation method thereof
US9623053B2 (en) * 2013-12-31 2017-04-18 Zhonglin Wang Pharmaceutical composition for treating AIDS and preparation method thereof
CN103948885A (en) * 2014-04-01 2014-07-30 孙志芳 Traditional Chinese medicine for treating gastric cancer, and preparation method thereof
CN104398904A (en) * 2014-12-13 2015-03-11 刘江梅 Chinese herbal preparation for oral care after esophagus cancer surgery and preparation method
CN104398904B (en) * 2014-12-13 2015-07-08 刘江梅 Chinese herbal preparation for oral care after esophagus cancer surgery and preparation method
CN106177368A (en) * 2016-10-10 2016-12-07 南宁多灵生物科技有限公司 A kind of Chinese medicine composition treating bladder cancer
CN108853236A (en) * 2018-02-28 2018-11-23 西安交通大学 A kind of Chinese medicine compound prescription application in preparation of anti-tumor drugs

Similar Documents

Publication Publication Date Title
CN101468171B (en) Medicament for weight-reducing of fat people and weight-gaining of thin people
CN101474387A (en) Chinese medicine preparation for treating prostatic disorders, frequent urination, swelling pain of muscle, impotence, premature ejaculation and other diseases
CN100478014C (en) Chinese medicinal preparation for treating lung cancer and production thereof
CN102335374A (en) Medicine special for treating lung cancer
CN101683499A (en) Cancer curing capsule
CN1634430A (en) Chinese traditional medicine composition for resisting malignant tumor (cancer)
CN110960619A (en) Traditional Chinese medicine composition for treating African swine fever
CN102423442B (en) Double-component medicine for treating fatty liver and preparation method thereof
CN1164317C (en) Zaizao Pill for treating woman diseases
CN101926956A (en) Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer
CN1052413C (en) Yinhuang Ganfu powder for curing hepatitis
CN102671096A (en) Traditional Chinese medicine for treating ulcer colonitis and preparation method thereof
CN104547785A (en) Traditional Chinese medicine for treating hepatitis
CN104352942A (en) Traditional Chinese medicine composition for treating diabetes
CN102309601A (en) Traditional Chinese medicine (TCM) prescription for treating chloasma
CN101284113A (en) Yin toxin Qingyuan pellet
CN100569263C (en) A kind of pharmaceutical composition for the treatment of stomachache and preparation method thereof
CN1218706C (en) Hepatitis B treaitng pill
CN101062347A (en) Chinese traditional medicine formula good for heart and brain
CN102671160A (en) Traditional Chinese medicine decoction for treating edema and preparation method of traditional Chinese medicine decoction
CN101850072A (en) Chinese patent medicament for treating hepatitis B
CN102423441A (en) Double-formula medicine used for treating constipation, and preparation method thereof
CN1240415C (en) Tablets against allergic purpura
CN105412522A (en) Preparing method for Shengbai oral liquid
CN104873802A (en) Traditional Chinese medicine composition for treating nephropyelitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20100331